The metabolic burden of creatine synthesis.
Level 5 - mechanism / opinion, no new human data
Narrative biochemical review and metabolic accounting without new human trial data
PubMed 21387089 · doi:10.1007/s00726-011-0853-y
What was done
This review analyzed the biochemical pathway and stoichiometric requirements of de novo creatine synthesis (utilizing glycine, methionine, and arginine via AGAT, MAT, and GAMT enzymes) to quantify its metabolic burden in humans and animals across different diets.
What was found
Daily creatinine loss averages approximately 2 g (14.6 mmol) in 70-kg males aged 20–39 years, with lower losses observed in females and older adults due to lower muscle mass. Omnivores replace approximately half of lost creatine via diet, whereas vegetarians must replace virtually all loss via endogenous synthesis. De novo creatine synthesis does not significantly burden glycine metabolism but accounts for approximately 40% of all labile methyl groups provided by S-adenosylmethionine (SAM) and consumes 20% to 30% of arginine amidino groups.
Why it matters
Endogenous creatine synthesis represents a major quantitative consumer of methionine-derived methyl groups and arginine amidino groups, illustrating a significant metabolic demand that increases substantially in the absence of dietary creatine.
Limits
This paper is a narrative review presenting biochemical calculations and estimates rather than direct empirical measurements or clinical trial data. Variations based on specific health conditions or detailed dietary sub-types beyond omnivorous versus vegetarian diets were not evaluated.
Cited by
- supports Creatine is found naturally only in animal products like beef and fish, and is absent from non-animal products.